 | Up a level |
Gorog, Diana A; Ferreiro, Jose Luis; Ahrens, Ingo; Ako, Junya; Geisler, Tobias; Halvorsen, Sigrun; Huber, Kurt; Jeong, Young-Hoon; Navarese, Eliano P; Rubboli, Andrea; Sibbing, Dirk; Siller-Matula, Jolanta M; Storey, Robert F; Tan, Jack W C; Ten Berg, Jurrien M; Valgimigli, Marco; Vandenbriele, Christophe; Lip, Gregory Y H (2023). De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis. Nature reviews. Cardiology, 20(12), pp. 830-844. Nature Publishing Group 10.1038/s41569-023-00901-2
Lyon, Alexander R; López-Fernández, Teresa; Couch, Liam S; Asteggiano, Riccardo; Aznar, Marianne C; Bergler-Klein, Jutta; Boriani, Giuseppe; Cardinale, Daniela; Cordoba, Raul; Cosyns, Bernard; Cutter, David J; de Azambuja, Evandro; de Boer, Rudolf A; Dent, Susan F; Farmakis, Dimitrios; Gevaert, Sofie A; Gorog, Diana A; Herrmann, Joerg; Lenihan, Daniel; Moslehi, Javid; ... (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European heart journal, 43(41), pp. 4229-4361. Oxford University Press 10.1093/eurheartj/ehac244
Piccini, Jonathan P; Caso, Valeria; Connolly, Stuart J; Fox, Keith A A; Oldgren, Jonas; Jones, W Schuyler; Gorog, Diana A; Durdil, Václav; Viethen, Thomas; Neumann, Christoph; Mundl, Hardi; Patel, Manesh R (2022). Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. The lancet, 399(10333), pp. 1383-1390. Elsevier 10.1016/S0140-6736(22)00456-1
